Johnson & Johnson (NYSE: JNJ) stock closed at 153.89 per share at the end of the most recent trading day (a 0.99% change compared to the prior day closing price) with a volume of 7.00M shares and market capitalization of 478.10B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 136400 people. Johnson & Johnson CEO is Alex Gorsky.

The one-year performance of Johnson & Johnson stock is -12.48%, while year-to-date (YTD) performance is -12.88%. JNJ stock has a five-year performance of 17.3%. Its 52-week range is between 150.71 and 186.69, which gives JNJ stock a 52-week price range ratio of 7.05%

Johnson & Johnson currently has a PE ratio of 25.10, a price-to-book (PB) ratio of 6.32, a price-to-sale (PS) ratio of 6.44, a price to cashflow ratio of 22.30, a PEG ratio of 2.32, a ROA of 11.12%, a ROC of 18.10% and a ROE of 27.18%. The company’s profit margin is 20.24%, its EBITDA margin is 30.80%, and its revenue ttm is $71.24 Billion , which makes it $27.25 revenue per share.

Of the last four earnings reports from Johnson & Johnson, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.51 for the next earnings report. Johnson & Johnson’s next earnings report date is 18th Apr 2023.

The consensus rating of Wall Street analysts for Johnson & Johnson is Moderate Buy (2.17), with a target price of $185.69, which is +20.75% compared to the current price. The earnings rating for Johnson & Johnson stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Johnson & Johnson has a dividend yield of 2.57% with a dividend per share of $4.52 and a payout ratio of 61.00%.

Johnson & Johnson has a Sell technical analysis rating based on Technical Indicators (ADX : 9.53, ATR14 : 2.34, CCI20 : -36.98, Chaikin Money Flow : -0.14, MACD : -2.44, Money Flow Index : 39.91, ROC : 0.94, RSI : 41.27, STOCH (14,3) : 57.40, STOCH RSI : 1.00, UO : 49.62, Williams %R : -42.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Johnson & Johnson in the last 12-months were: Alex Gorsky (Option Excercise at a value of $39 729 576), Ashley McEvoy (Option Excercise at a value of $10 637 700), Ashley McEvoy (Sold 146 646 shares of value $25 731 602 ), Elizabeth Forminard (Option Excercise at a value of $0), James D. Swanson (Option Excercise at a value of $0), James D. Swanson (Sold 1 062 shares of value $164 199 ), Jennifer L. Taubert (Option Excercise at a value of $5 579 994), Jennifer L. Taubert (Sold 76 923 shares of value $13 598 402 ), Joaquin Duato (Option Excercise at a value of $21 549 894), Joseph J. Wolk (Option Excercise at a value of $1 303 589), Joseph J. Wolk (Sold 14 781 shares of value $2 654 661 ), Kathryn E. Wengel (Option Excercise at a value of $5 282 362), Kathryn E. Wengel (Sold 72 820 shares of value $12 611 585 ), Peter M. Fasolo (Option Excercise at a value of $16 218 972), Peter M. Fasolo (Sold 50 881 shares of value $8 699 257 ), Robert J. Decker (Option Excercise at a value of $3 675 770), Robert J. Decker (Sold 42 318 shares of value $7 447 960 ), Thibaut Mongon (Option Excercise at a value of $12 967 573), Thibaut Mongon (Sold 70 492 shares of value $12 066 608 ), Vanessa Broadhurst (Option Excercise at a value of $0), William Hait (Option Excercise at a value of $4 042 577), William Hait (Sold 44 599 shares of value $8 006 915 )